Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gust H Bardy

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Heart Rhythm|October 2, 2010
An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure TrialDavid G Strauss, Jeanne E Poole, Galen S Wagner, et al.
Resuscitation|September 9, 2021
Outcomes for patients with anterior myocardial infarction and prior cardiac arrest in the home automated external defibrillator trial (HAT)Monique Anderson Starks, Larry R Jackson, Anne Hellkamp, et al.
Journal of the American College of Cardiology|June 27, 2002
Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trialRichard L Page, Richard E Kerber, James K Russell, et al.
American Heart Journal|November 27, 2008
Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Lorne J Gula, George J Klein, Anne S Hellkamp, et al.
Circulation|July 5, 2006
Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Daniel B Mark, Charlotte L Nelson, Kevin J Anstrom, et al.
Circulation|August 26, 2009
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure populationWayne C Levy, Kerry L Lee, Anne S Hellkamp, et al.
American Heart Journal|June 25, 2005
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004Sana M Al-Khatib, Gillian D Sanders, Daniel B Mark, et al.
Journal of the American College of Cardiology|July 25, 2020
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJeanne E Poole, Brian Olshansky, Daniel B Mark, et al.
American Heart Journal|April 6, 2010
Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT)Daniel B Mark, Kevin J Anstrom, Steven E McNulty, et al.
JAMA|January 3, 2013
Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trialsSana M Al-Khatib, Anne Hellkamp, Gust H Bardy, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Heart Rhythm|October 2, 2010
An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure TrialDavid G Strauss, Jeanne E Poole, Galen S Wagner, et al.
Resuscitation|September 9, 2021
Outcomes for patients with anterior myocardial infarction and prior cardiac arrest in the home automated external defibrillator trial (HAT)Monique Anderson Starks, Larry R Jackson, Anne Hellkamp, et al.
Journal of the American College of Cardiology|June 27, 2002
Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trialRichard L Page, Richard E Kerber, James K Russell, et al.
American Heart Journal|November 27, 2008
Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Lorne J Gula, George J Klein, Anne S Hellkamp, et al.
Circulation|July 5, 2006
Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Daniel B Mark, Charlotte L Nelson, Kevin J Anstrom, et al.
Circulation|August 26, 2009
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure populationWayne C Levy, Kerry L Lee, Anne S Hellkamp, et al.
American Heart Journal|June 25, 2005
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004Sana M Al-Khatib, Gillian D Sanders, Daniel B Mark, et al.
Journal of the American College of Cardiology|July 25, 2020
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJeanne E Poole, Brian Olshansky, Daniel B Mark, et al.
American Heart Journal|April 6, 2010
Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT)Daniel B Mark, Kevin J Anstrom, Steven E McNulty, et al.
JAMA|January 3, 2013
Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trialsSana M Al-Khatib, Anne Hellkamp, Gust H Bardy, et al.
Pageof 7